Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal peptide peptidase-like 2A pseudogene (ENSG00000259531) is a nonfunctional genomic sequence highly similar to the functional Signal peptide peptidase-like 2A (SPPL2A) gene. Pseudogenes resemble their parent genes but are typically unable to encode functional proteins, lacking necessary regulatory elements or containing mutations such as frameshifts or premature stop codons. This pseudogene does not have known biological function, does not participate in disease processes, is not a drug target, and should not be confused with the functional SPPL2A gene, which encodes an intramembrane aspartyl protease involved in immune functions[2][8]. SPPL2A is a functional gene in the same family, encodes a protein involved in immune regulation, and is a drug development target, but ENSG00000259531 only refers to its pseudogene[1][9]. Pseudogenes can complicate genetic and molecular studies by being mistakenly annotated as functional genes or by cross-reactivity in certain assays[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptide peptidase-like 2A pseudogene.